Last 12 months
Inside the activity.
0 purchase rows · 55 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 14 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2021 Filed Sep 17, 2021 22:42 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 7,000 | $38.12 | $266,840.00 |
DisclosureSEC source: 0001209191-21-056727 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,814 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $38.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:58 UTC |
Sung DerrickChief Financial Officer
|
SaleCommon Stock | 383 | $40.09 | $15,354.47 |
DisclosureSEC source: 0001209191-21-054861 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,803 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:55 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 355 | $40.09 | $14,231.95 |
DisclosureSEC source: 0001209191-21-054860 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,814 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. F2 · balance_after: Includes 284 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on August 13, 2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:53 UTC |
Lehman David AaronGeneral Counsel
|
SaleCommon Stock | 383 | $40.09 | $15,354.47 |
DisclosureSEC source: 0001209191-21-054858 · doc4.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,217 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:50 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 1,421 | $40.09 | $56,967.89 |
DisclosureSEC source: 0001209191-21-054857 · doc4.xml · nonDerivative · entry 1 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,180,370 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:47 UTC |
Lynch Alissa HsuDirector
|
GrantCommon Stock | 4,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054851 · doc4.xml · nonDerivative · entry 1 Lynch Alissa Hsu · CIK 0001875681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,610 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest in three equal annual installments from the grant date of September 1, 2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:48 UTC |
Sullivan TiffanyDirector
|
GrantCommon Stock | 4,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054854 · doc4.xml · nonDerivative · entry 1 Sullivan Tiffany · CIK 0001876368 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,610 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest in three equal annual installments from the grant date of September 1, 2021. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 22:31 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 25,000 | $36.63 | $915,750.00 |
DisclosureSEC source: 0001209191-21-053007 · doc4.xml · nonDerivative · entry 2 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181,791 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $37.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · balance_after: Includes 57 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 13, 2021. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 22:31 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 1,000 | $36.59 | $36,590.00 |
DisclosureSEC source: 0001209191-21-053007 · doc4.xml · nonDerivative · entry 1 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 23,571 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020. F2 · ownership.nature: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee. Read SEC document |
| August 16, 2021 Filed Aug 19, 2021 00:09 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 7,000 | $36.71 | $256,970.00 |
DisclosureSEC source: 0001209191-21-052427 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.39 to $37.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:49 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 100 | $39.24 | $3,924.00 |
DisclosureSEC source: 0001209191-21-047262 · doc4.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:49 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 6,142 | $38.86 | $238,678.12 |
DisclosureSEC source: 0001209191-21-047262 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,985 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.20 to $39.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:49 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 758 | $37.57 | $28,478.06 |
DisclosureSEC source: 0001209191-21-047262 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,127 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.14 to $38.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:48 UTC |
French Glendon E. IIIDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,375 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001209191-21-047261 · doc4.xml · derivative · entry 8 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,249 Underlying: Common Stock · 4,375 shares Expires 2030-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:48 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 807 | $38.90 | $31,392.30 |
DisclosureSEC source: 0001209191-21-047261 · doc4.xml · nonDerivative · entry 7 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 24,571 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · ownership.nature: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:48 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 100 | $38.20 | $3,820.00 |
DisclosureSEC source: 0001209191-21-047261 · doc4.xml · nonDerivative · entry 6 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 25,378 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020. F5 · ownership.nature: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:48 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 93 | $37.53 | $3,490.29 |
DisclosureSEC source: 0001209191-21-047261 · doc4.xml · nonDerivative · entry 5 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 25,478 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020. F5 · ownership.nature: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:48 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 12,500 | $38.73 | $484,125.00 |
DisclosureSEC source: 0001209191-21-047261 · doc4.xml · nonDerivative · entry 4 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,206,734 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:48 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 11,163 | $38.86 | $433,794.18 |
DisclosureSEC source: 0001209191-21-047261 · doc4.xml · nonDerivative · entry 3 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219,234 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.20 to $39.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:48 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 1,337 | $37.61 | $50,284.57 |
DisclosureSEC source: 0001209191-21-047261 · doc4.xml · nonDerivative · entry 2 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,230,397 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.14 to $38.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:48 UTC |
French Glendon E. IIIDirector · President and CEO
|
Exercise / conversionCommon Stock | 4,375 | $2.20 | $9,625.00 |
DisclosureSEC source: 0001209191-21-047261 · doc4.xml · nonDerivative · entry 1 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,231,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:10 UTC |
BOSTON SCIENTIFIC CORP10% owner
|
SaleCommon Stock | 2,500,000 | $37.45 | $93,625,000.00 |
DisclosureSEC source: 0001225208-21-010646 · doc4.xml · nonDerivative · entry 1 BOSTON SCIENTIFIC CORP · CIK 0000885725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488,106 F1 · kind: These shares of the Issuer's common stock were sold in a block order at a price of $37.45. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 23:21 UTC |
Florin Daniel PDirector
|
PurchaseCommon Stock | 2,500 | $40.00 | $100,000.00 |
DisclosureSEC source: 0001209191-21-046602 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,532 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 21:33 UTC |
Florin Daniel PDirector
|
PurchaseCommon Stock | 2,222 | $44.12 | $98,034.64 |
DisclosureSEC source: 0001209191-21-043518 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,032 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.68 to $44.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 22:26 UTC |
French Glendon E. IIIDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,375 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001209191-21-042216 · doc4.xml · derivative · entry 5 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,624 Underlying: Common Stock · 4,375 shares Expires 2030-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 22:26 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 1,000 | $42.68 | $42,680.00 |
DisclosureSEC source: 0001209191-21-042216 · doc4.xml · nonDerivative · entry 4 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 25,571 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020. F5 · ownership.nature: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 22:26 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 4,929 | $43.47 | $214,263.63 |
DisclosureSEC source: 0001209191-21-042216 · doc4.xml · nonDerivative · entry 3 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,227,359 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.27 to $43.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 22:26 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 20,071 | $42.83 | $859,640.93 |
DisclosureSEC source: 0001209191-21-042216 · doc4.xml · nonDerivative · entry 2 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,232,288 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.27 to $43.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 22:26 UTC |
French Glendon E. IIIDirector · President and CEO
|
Exercise / conversionCommon Stock | 4,375 | $2.20 | $9,625.00 |
DisclosureSEC source: 0001209191-21-042216 · doc4.xml · nonDerivative · entry 1 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,252,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:12 UTC |
Ferrari RichardDirector
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040067 · doc4.xml · nonDerivative · entry 1 FERRARI RICHARD M · CIK 0001034413 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,997 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:24 UTC |
Sung DerrickChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,900 | $0.00 Strike: $43.40 | $0.00 |
DisclosureSEC source: 0001209191-21-040077 · doc4.xml · derivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,900 Underlying: Common Stock · 39,900 shares Expires 2031-05-31 F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:24 UTC |
Sung DerrickChief Financial Officer
|
GrantCommon Stock | 17,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040077 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,186 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021. F2 · balance_after: Includes 1,927 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 24, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:22 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,900 | $0.00 Strike: $43.40 | $0.00 |
DisclosureSEC source: 0001209191-21-040076 · doc4.xml · derivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,900 Underlying: Common Stock · 39,900 shares Expires 2031-05-31 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:22 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
GrantCommon Stock | 17,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040076 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,885 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:20 UTC |
Melenikiotou GeorgiaDirector
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040074 · doc4.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,810 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:18 UTC |
Mead Dana G Jr.Director
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040072 · doc4.xml · nonDerivative · entry 1 Mead Dana G Jr. · CIK 0001222358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,125 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:15 UTC |
French Glendon E. IIIDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 103,700 | $0.00 Strike: $43.40 | $0.00 |
DisclosureSEC source: 0001209191-21-040070 · doc4.xml · derivative · entry 3 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,700 Underlying: Common Stock · 103,700 shares Expires 2031-05-31 F4 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:15 UTC |
French Glendon E. IIIDirector · President and CEO
|
GrantCommon Stock | 45,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040070 · doc4.xml · nonDerivative · entry 1 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,247,984 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021. F2 · balance_after: Includes 2,500 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 24, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:16 UTC |
Lehman David AaronGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,900 | $0.00 Strike: $43.40 | $0.00 |
DisclosureSEC source: 0001209191-21-040071 · doc4.xml · derivative · entry 2 Lehman David Aaron · CIK 0001354228 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,900 Underlying: Common Stock · 39,900 shares Expires 2031-05-31 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:16 UTC |
Lehman David AaronGeneral Counsel
|
GrantCommon Stock | 17,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040071 · doc4.xml · nonDerivative · entry 1 Lehman David Aaron · CIK 0001354228 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,600 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:14 UTC |
Florin Daniel PDirector
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040068 · doc4.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,810 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:10 UTC |
Burns Thomas WilliamDirector
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040066 · doc4.xml · nonDerivative · entry 1 Burns Thomas William · CIK 0001644557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,810 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:18 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 400 | $41.55 | $16,620.00 |
DisclosureSEC source: 0001209191-21-035741 · doc4.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,285 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:18 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 10 | $41.52 | $415.20 |
DisclosureSEC source: 0001209191-21-035741 · doc4.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,685 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:18 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 24 | $41.49 | $995.76 |
DisclosureSEC source: 0001209191-21-035741 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,695 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:18 UTC |
Rose Geoffrey BeranChief Commercial Officer
|
SaleCommon Stock | 4,363 | $40.81 | $178,054.03 |
DisclosureSEC source: 0001209191-21-035741 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,719 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.42 to $41.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 1,981 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 24, 2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:25 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 1,000 | $40.75 | $40,750.00 |
DisclosureSEC source: 0001209191-21-035021 · doc4.xml · nonDerivative · entry 3 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 26,571 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Glendon E. French III Children's Irrevocable Trust on December 15, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.54 to $41.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F6 · ownership.nature: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:25 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 19,941 | $42.19 | $841,310.79 |
DisclosureSEC source: 0001209191-21-035021 · doc4.xml · nonDerivative · entry 2 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,199,884 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.85 to $42.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:25 UTC |
French Glendon E. IIIDirector · President and CEO
|
SaleCommon Stock | 5,059 | $41.01 | $207,469.59 |
DisclosureSEC source: 0001209191-21-035021 · doc4.xml · nonDerivative · entry 1 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,219,825 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.71 to $41.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 20, 2021 Filed Dec 4, 2021 00:08 UTC Amendment |
French Glendon E. IIIDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001209191-21-067997 · doc4a.xml · derivative · entry 4 French Glendon E. III · CIK 0001805624 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,999 Underlying: Common Stock · 10,000 shares Expires 2030-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.